Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ratcliffe CDH"'
Autor:
Loukas I; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Simeoni F; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Milan M; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Inglese P; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Patel H; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Goldstone R; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., East P; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Strohbuecker S; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Mitter R; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Talsania B; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Tang W; Department of Mathematics, Imperial College London, London, UK., Ratcliffe CDH; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Shahrezaei V; Department of Mathematics, Imperial College London, London, UK., Scaffidi P; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK. Electronic address: paola.scaffidi@crick.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 70-87.e14. Date of Electronic Publication: 2022 Nov 03.
Autor:
Coelho PP; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.; Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada., Hesketh GG; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 992A-600 University Avenue, Toronto, M5G 1X5, Canada., Pedersen A; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.; Department of Experimental Medicine, McGill University, Montreal, Canada., Kuzmin E; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.; Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada., Fortier AN; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada., Bell ES; Department of Biochemistry and Molecular Biology, Pennsylvania State University, State College, PA, 16802, USA., Ratcliffe CDH; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.; Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada., Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 992A-600 University Avenue, Toronto, M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Canada., Park M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada. morag.park@mcgill.ca.; Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada. morag.park@mcgill.ca.; Department of Medicine, McGill University, Montreal, Canada. morag.park@mcgill.ca.; Department of Oncology, McGill University, Montreal, H2W 1S6, Canada. morag.park@mcgill.ca.
Publikováno v:
Nature communications [Nat Commun] 2022 Jul 02; Vol. 13 (1), pp. 3812. Date of Electronic Publication: 2022 Jul 02.
Autor:
Tehranian C; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Fankhauser L; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Harter PN; Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany.; German Cancer Research Center DKFZ Heidelberg, Germany and German Cancer Consortium DKTK partner site, Frankfurt/Mainz Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Ratcliffe CDH; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Zeiner PS; Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany.; Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Messmer JM; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Hoffmann DC; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Frey K; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Westphal D; Department of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Ronellenfitsch MW; Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Karreman MA; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Winkler F; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2022 Feb 01; Vol. 24 (2), pp. 213-225.
Autor:
Zangrossi M; Department of Molecular Medicine, University of Padua, Viale G. Colombo, 3, 35126 Padua, Italy., Romani P; Department of Molecular Medicine, University of Padua, Viale G. Colombo, 3, 35126 Padua, Italy., Chakravarty P; Bioinformatics Platform, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Ratcliffe CDH; Tumor Cell Biology Lab, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Hooper S; Tumor Cell Biology Lab, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Dori M; Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi, 287, 41125 Modena, Italy., Forcato M; Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi, 287, 41125 Modena, Italy., Bicciato S; Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi, 287, 41125 Modena, Italy., Dupont S; Department of Molecular Medicine, University of Padua, Viale G. Colombo, 3, 35126 Padua, Italy., Sahai E; Tumor Cell Biology Lab, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Montagner M; Department of Molecular Medicine, University of Padua, Viale G. Colombo, 3, 35126 Padua, Italy.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Mar 03; Vol. 13 (5). Date of Electronic Publication: 2021 Mar 03.
Autor:
Kondo H; Tumor Cell Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Ratcliffe CDH; Tumor Cell Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Hooper S; Tumor Cell Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Ellis J; Metabolomics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., MacRae JI; Metabolomics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Hennequart M; p53 and Metabolism Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Dunsby CW; Photonics Group, Physics Department, Imperial College London, London, SW7 2AZ, UK., Anderson KI; Crick Advanced Light Microscopy Facility, The Francis Crick Institute, London, NW1 1AT, UK. Electronic address: kurt.anderson@crick.ac.uk., Sahai E; Tumor Cell Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK. Electronic address: erik.sahai@crick.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2021 Feb 16; Vol. 34 (7), pp. 108750.
Autor:
Montagner M; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. marco.montagner@unipd.it.; Department of Molecular Medicine, University of Padua, Padova, Italy. marco.montagner@unipd.it., Bhome R; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Hooper S; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Chakravarty P; Bioinformatics Platform, The Francis Crick Institute, London, UK., Qin X; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK., Sufi J; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK., Bhargava A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Ratcliffe CDH; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Naito Y; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Pocaterra A; Department of Molecular Medicine, University of Padua, Padova, Italy., Tape CJ; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. erik.sahai@crick.ac.uk.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2020 Mar; Vol. 22 (3), pp. 289-296. Date of Electronic Publication: 2020 Feb 24.
LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion.
Autor:
Bell ES; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada., Coelho PP; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada., Ratcliffe CDH; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada., Rajadurai CV; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada., Peschard P; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada., Vaillancourt R; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada., Zuo D; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada., Park M; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montreal, QC H3A 1A3, Canada; Department of Oncology, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: morag.park@mcgill.ca.
Publikováno v:
Cell reports [Cell Rep] 2019 Dec 17; Vol. 29 (12), pp. 4053-4068.e6.
Autor:
Ratcliffe CDH; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Siddiqui N; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Coelho PP; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Laterreur N; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada., Cookey TN; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada., Sonenberg N; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Park M; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada morag.park@mcgill.ca.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University, Montreal, Quebec, Canada.; Department of Oncology, McGill University, Montreal, Quebec, Canada.
Publikováno v:
The Journal of cell biology [J Cell Biol] 2019 Jan 07; Vol. 218 (1), pp. 285-298. Date of Electronic Publication: 2018 Nov 07.
Autor:
Knight JF; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Sung VYC; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada., Kuzmin E; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada., Couzens AL; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada., de Verteuil DA; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Ratcliffe CDH; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada., Coelho PP; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada., Johnson RM; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Samavarchi-Tehrani P; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada., Gruosso T; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Oncology, McGill University, Montreal, QC H2W 1S6, Canada., Smith HW; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Lee W; Department of Biomedical Engineering, McGill University, Montreal, QC H3A 2B4, Canada., Saleh SM; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Zuo D; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Zhao H; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada., Guiot MC; Montreal Neurological Institute, Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada., Davis RR; Department of Pathology and Laboratory Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA., Gregg JP; Department of Pathology and Laboratory Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA., Moraes C; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biomedical Engineering, McGill University, Montreal, QC H3A 2B4, Canada; Department of Chemical Engineering, McGill University, Montreal, QC H3A 0C5, Canada., Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada., Park M; Goodman Cancer Research Centre, McGill University, Montreal, QC H3G 0B1, Canada; Department of Biochemistry, McGill University, Montreal, QC H2W 1S6, Canada; Department of Oncology, McGill University, Montreal, QC H2W 1S6, Canada. Electronic address: morag.park@mcgill.ca.
Publikováno v:
Cell reports [Cell Rep] 2018 Mar 20; Vol. 22 (12), pp. 3191-3205.